2,4-diamino-6-(2-thienyl)-1,3,5-triazine | 35841-87-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 三嗪类
• 英文名称: 2,4-diamino-6-(2-thienyl)-1,3,5-triazine
• 英文别名: 6-(Thiophen-2-yl)-1,3,5-triazine-2,4-diamine；6-thiophen-2-yl-1,3,5-triazine-2,4-diamine
• CAS: 35841-87-3
• 化学式: C₇H₇N₅S
• 分子量: 193.232
• InChiKey: ATTKZMCIEMDLPY-UHFFFAOYSA-N

物化性质

• 熔点：
  245-247 °C
• 沸点：
  527.0±42.0 °C(Predicted)
• 密度：
  1.504±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  119
• 氢给体数：
  2
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  2,4-diamino-6-(2-thienyl)-1,3,5-triazine 在 N-溴代丁二酰亚胺(NBS) 作用下， 以 溶剂黄146 为溶剂， 反应 48.0h， 以90%的产率得到6-(5-bromothiophen-2-yl)-1,3,5-triazine-2,4-diamine
  参考文献：
  名称：

  Method useful for amplifying, detecting and depleting pathologic forms of the cellular prion protein

  摘要：

  本发明涉及一种选择性放大PrPC细胞朊蛋白的至少一种PrPSc异构体的寡聚化的方法，其特点在于包括将所述PrPSc异构体，在适宜放大的条件下，与至少一种一般式I化合物的有效量一起结合。该即时发明还涉及一般式I的新化合物和包括它们的药物组合物。

  公开号：

  EP2072511A1
• 作为产物：
  描述：

  2-噻吩甲醛 在 ammonium hydroxide 、 碘 作用下， 以 四氢呋喃 、 水 为溶剂， 反应 1.0h， 生成 2,4-diamino-6-(2-thienyl)-1,3,5-triazine
  参考文献：
  名称：

  Microwave-Assisted One-Pot Tandem Reactions for Direct Conversion of Primary Alcohols and Aldehydes to Triazines and Tetrazoles in Aqueous Media

  摘要：

  A series of primary alcohols and aldehydes were treated with iodine in ammonia water under microwave irradiation to give the intermediate nitriles, which without isolation underwent [2 + 3] cycloadditions with dicyandiamide and sodium azide to afford high yields of the corresponding triazines and tetrazoles, including the alpha-amino- and dipeptidyl tetrazoles in high optical purity.

  DOI：

  10.1021/jo0625352

文献信息

• Direct Conversion of Aldehydes to Amides, Tetrazoles, and Triazines in Aqueous Media by One-Pot Tandem Reactions
  作者：Jiun-Jie Shie、Jim-Min Fang

  DOI：10.1021/jo026407z

  日期：2003.2.1

  A variety of aldehydes reacted with iodine in ammonia water at room temperature to give the nitrile intermediates, which were trapped by addition of hydrogen peroxide, sodium azide, or dicyandiamide to produce their corresponding amides, tetrazoles, and 1,3,5-triazines in modest to high yields. The one-pot tandem reactions were conducted in water media, and the products were obtained simply by extraction

  在室温下，各种醛在氨水中与碘反应生成腈中间体，通过添加过氧化氢，叠氮化钠或双氰胺将其捕集，以生成相应的酰胺，四唑和1,3,5-三嗪中等至高产。一锅串联反应在水介质中进行，只需萃取或过滤即可获得产物。
• 2,4,6-三取代-1,3,5-均三嗪类化合物及制备和应用
  申请人：浙江大学

  公开号：CN113461660B

  公开（公告）日：2022-08-02

  本发明提供2,4,6‑三取代‑1,3,5‑均三嗪类化合物及制备和应用，以双胍或二甲基双胍盐酸盐为起始原料，在碱性条件下与氰基化合物反应制备。本发明提供一种简便的2,4,6‑三取代‑1,3,5‑均三嗪类化合物合成方法，利用本发明提供的化合物可在制备抗髓系白血病药物恩西地平药物中的应用。本发明制备恩西地平的方法与现有技术相比减少了两步反应，避免了卤化试剂的使用，为绿色环保的化工过程。结构式Ⅰ如下所示：
• [EN] METHOD USEFUL FOR AMPLIFYING, DETECTING AND DEPLETING PATHOLOGIC FORMS OF THE CELLULAR PRION PROTEIN<br/>[FR] PROCÉDÉ UTILISÉ POUR AMPLIFIER, DÉTECTER ET RÉDUIRE LES FORMES PATHOLOGIQUES DE LA PROTÉINE PRION CELLULAIRE
  申请人：INST NAT SANTE RECH MED

  公开号：WO2009081372A1

  公开（公告）日：2009-07-02

  The present invention relates to a method for selectively amplifying the oligomerization of at least one PrPSc isoform of the PrPc cellular prion protein, characterized in that it comprises bringing said PrPSc isoform, under conditions suitable for amplification, together with an effective amount of at least one compound of general formula (I) as follow: The instant invention is also directed to new compounds of formula (I) and pharmaceutical compositions including them.
• Microwave-Assisted One-Pot Tandem Reactions for Direct Conversion of Primary Alcohols and Aldehydes to Triazines and Tetrazoles in Aqueous Media
  作者：Jiun-Jie Shie、Jim-Min Fang

  DOI：10.1021/jo0625352

  日期：2007.4.1

  A series of primary alcohols and aldehydes were treated with iodine in ammonia water under microwave irradiation to give the intermediate nitriles, which without isolation underwent [2 + 3] cycloadditions with dicyandiamide and sodium azide to afford high yields of the corresponding triazines and tetrazoles, including the alpha-amino- and dipeptidyl tetrazoles in high optical purity.
• Method useful for amplifying, detecting and depleting pathologic forms of the cellular prion protein
  申请人：INSERM (Institut National de la Santé et de la Recherche Médicale)

  公开号：EP2072511A1

  公开（公告）日：2009-06-24

  The present invention relates to a method for selectively amplifying the oligomerization of at least one PrPSc isoform of the PrPC cellular prion protein, characterized in that it comprises bringing said PrPSc isoform, under conditions suitable for amplification, together with an effective amount of at least one compound of general formula I as follow: The instant invention is also directed to new compounds of formula I and pharmaceutical compositions including them.

  本发明涉及一种选择性放大PrPC细胞朊蛋白的至少一种PrPSc异构体的寡聚化的方法，其特点在于包括将所述PrPSc异构体，在适宜放大的条件下，与至少一种一般式I化合物的有效量一起结合。该即时发明还涉及一般式I的新化合物和包括它们的药物组合物。